Orchestra Medical Ventures

Orchestra BioMed develops transformative therapeutic products addressing significant unmet clinical needs in procedure-based medicine. The company specializes in creating high-impact solutions, designing and advancing novel therapies to notably improve patient outcomes. Its core approach identifies critical deficiencies in current interventional procedures, engineering targeted medical devices.

The company traces its roots to Orchestra Medical Ventures, an investment firm founded in 2000 by David P. Hochman and Darren R. Sherman. This entity, evolving from Accelerated Technologies Partners, was established with the insight of creating and nurturing medical technology companies. Hochman and Sherman utilized their experience in healthcare entrepreneurship and venture capital to build operating enterprises.

Orchestra BioMed's solutions serve patients undergoing diverse interventional medical procedures. The company collaborates with leading medical device firms to commercialize innovations, aiming for widespread patient access. Its forward-looking vision is to expand the development and delivery of transformative products globally, continually enhancing standards of care in procedural medicine.